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Abstract 
Background: Cost effectiveness, the ratio of relative costs of a program to its desired outcomes, is one 
of the basic issues in various screening programs performed to detect opium abuse. This study aimed 
to find the cost-effectiveness of opiates abuse screening through urine analysis. 
Methods: A total number of 64698 individuals were selected and divided into to five distinct groups 
based on the reason for which they were tested. Cost-effectiveness of opiates abuse screening in each 
group was calculated by dividing the total cost, including personnel and overhead costs, to the number 
of detected cases. Finally, the results were compared. 
Findings: The total number of positive cases based on rapid screening assay (RSA) and thin layer 
chromatography (TLC) was 3460 (5.3%). According to incremental cost-effectiveness analysis, 
screening program of the group referred by the police was the most cost-effective program with the 
breakeven point at 2%. 
Conclusion: According to the obtained results, continuation of drug abuse screening programs is 
recommended. 
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Introduction  
The high number of drug abusers in Iran has 
caused a worrisome condition for people and 
authorities. According to recent studies, opium 
and its derivatives continue to be the most 
frequent used drugs in Iran.1 Likewise, official 
statistics indicated Iran as one of the countries 
with the highest number of opium consumers 
throughout the world.2 In 1997, 2.4% of 960000 
individuals screened for drug abuse in pre-
marriage and pre-employment formalities tested 
positive for opiates abuse.1 Urine analysis is a 
common practice in all countries to detect drug 
abuse among various groups.3 Screening is 
performed in two major types of routine and 
individualized screening. While in routine 
screening, a large number of individuals are 
screened based on a scheduled program 
regardless of having any symptoms (for example 
during pre-marriage formalities), individualized 
screening only involves testing suspected 
individuals based on some evidences (like 
screening of police detainees). However, 
screening programs of any type should be 
assessed economically in specific intervals.4 In 
developed countries, economic evaluation of drug 
abuse screening programs has been conducted 
recently, even though they are limited.5,6 Since as 
far as the authors know, there are not such 
published studies in Iran, the present study was 
performed to investigate the cost-effectiveness of 
opiates abuse screening through urine analysis in 
five groups of male marriage applicants, 
governmental job applicants, private job 
applicants, and employees referred by Harasat 
(security department) of various offices. 
 
Methods 
This study was an economic evaluation of the 
abovementioned opiates screening programs 
through cost-effectiveness analysis. It consisted 
of two major parts, namely calculation of costs 
and determination of efficacy. 
 
Calculation of costs: 
Costs were determined using the documents of 
accounting, procurement and stockroom sections 
of the service provider (the Central Laboratory of 
Kerman University of Medical Sciences. 
The personnel (technical, non-technical and 
administrative) and supervisors were interviewed 
and their costs were calculated based on the 
percent of allotted time to the analysis of opiates 
compounds in urine and also their mean salary.7 
Overhead costs (water, electricity, telephone 
service, gas, and cleansing) were estimated 
based on the occupied space by opiates or 
morphine sections of urine analysis department. 
Capital costs (building, equipments, and 
transportation) were not considered due to the 
lack of documents. At the time of the study, 
10000 Iranian Rials equaled one U.S. dollar. 
 
Calculation of effectiveness: 
In order to detect opiates abuse in individuals, 
first, urine samples were collected under direct 
supervision. Then, primary screening [rapid 
screening assay (RSA)] designed for qualitative 
detection of opiates in urine was performed. This 
test is capable of identifying 300 ng/ml of opiate 
compounds in urine using monoclonal anti-
morphine antibody. Positive samples detected in 
primary screening are tested by thin layer 
chromatography (TLC) which identifies the type 
of opioid consumed (opium, heroine or 
morphine). However, TLC can only detect opiates 
if they had been used 17-35 hours prior to the 
test.3 Finally, the results of the mentioned tests are 
classified by documents and computer files.  
In the present study, the results of TLC were 
considered as the measure of effectiveness. 
Therefore, each case that tested positive in RSA 
and TLC was considered as one effectiveness unit. 
 
Calculation of cost-effectiveness: 
In order to calculate the cost-effectiveness ratio of 
urine opiates analysis in each screening program, 
the total cost was divided by the total number of 
positive TLC cases.8 Since all the programs used a 
common framework for screening, incremental 
cost-effectiveness analysis was used to compare 
different programs. For this purpose, cost of the 
program with less effectiveness was subtracted 
from the cost of the alternative program with 
more effectiveness and the result was divided by 
the difference of cost-effectiveness of the two 
programs (Figure 1). 
 
Sensitivity Analysis: 
Since statistical tests are not completely certain,9 
the impact of relative frequency of positive 
responses on costs was estimated and break-
even point or the least prevalence at which 
consumed costs by service provider was equal to 
the received price was determined.8 
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Figure 1. Incremental cost-effectiveness ratios of urine opiates screening programs (a: Harasat referrals, 
b: governmental job applicants, c: marriage applicants, d: private job applicants, e: police detainees). 
*: 10000 Iranian Rials equals one U.S. dollar. 
 
Table 1. Number and total costs (Iranian Rial**) of RSA and TLC tests performed and cost-effectiveness ratio in the 
five studied groups 
*: Security sections of governmental offices. 
**: 10000 Iranian Rials equals one U.S. dollar. 
 
Results 
Overall, 64698 cases of RSA (primary screening) 
were performed of which 8440 (13%) were 
positive. Most positive cases in the consequent 
TLC were observed in police detainees (22.1%) 
while the least positive cases (3.2%) were seen in 
the group referred by security sections of 
different offices. Totally, 41% of positive cases of 
RSA were confirmed by TLC. The total cost of 
performed tests was estimated 541137764 Rials 
of which the main part was for marriage 
applicants (Table 1). 
RSA and TLC per case prices were 18500 and 
31800 Rials, respectively. Therefore, 14655305000 
Rials was received from the subjects for 
screening tests. In incremental cost-effectiveness 
analysis, the most cost-effective programs were 
those for police detainees and judiciary referrals 
with the break-even point at 2%. 
 
Discussion 
During the last two decades, the rate of substance 
abuse has been growing more than three times as 
much as the rate of population growth. Due to the 
young population of our community and lack of 
sufficient cultural, entertaining and occupational 
facilities for them, the number of drug abusers is 
predicted to increase more dramatically in the 
Group 
Number of 
performed 
RSAs 
Positive cases 
Number (%) Total costs (Rial) Cost-effectiveness ratio (Rial) RSA TLC 
Harasat*referrals 8279 651 (7.9) 266 (3.2) 6924597.7 260393 
Governmental job 
applicants 9509 834 (8.8) 342 (3.6) 79555146.7 232617 
Male marriage 
applicants 31853 3397 (10.7) 1393 (4.4) 266346640.5 191204 
Private job applicants 10772 1244 (11.5) 510 (4.7) 90121783.6 176709 
Police detainees 4285 2314 (54) 949 (22.1) 35849595.5 37776 
Total 64698 8840 (13) 3460 (5.3) 541137764 156398 
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following years.10 Therefore, there should be more 
serious measures for drug abuse control. One of 
the prevention levels is secondary prevention or 
screening. Opiates abuse screening in various 
populations has been performed in our country 
for many years and considering insufficient 
facilities these tests should be analyzed 
economically.11,12 
According to the results of the present study, 
the highest cost-effectiveness ratio, in other 
words the highest cost of each detected positive 
case, was in referrals of security sections of 
offices. That is, the cost of each detected positive 
case was found to be 260000 Rials. Part of this 
might be due to the prescheduled screening in 
this group. In the most cost-effective screening 
program, i.e. police detainees and judiciary 
referrals, the cost of each detected positive case 
was 38000 Rials. The most populated screened 
group was male marriage applicants group in 
which the cost of each detected positive case was 
19000 Rials. Overall, the average cost of each 
detected case was 156000 Rials, while the 
average per case received price was 423000 Rials 
(resulted from dividing the total price of 
14655305000 by the total number of 3460 
detected case). Therefore, it can be said that even 
considering capital costs, these screenings are 
beneficial for the service provider. At the same 
time, it should be noted that for individuals 
referred by security sections of the offices, the 
price of each case was 653621 Rials and the 
breakeven point was at 2% which means that if 
the average of substance abuse prevalence in all 
groups decreases to 2%, the screening would be 
still cost-effective. In other words, the least 
prevalence in which the cost and price are equal 
is 2% (except for capital costs). 
Incremental cost-effectiveness analysis 
showed that in the screening programs of private 
jobs and police detainees, cost-effectiveness has a 
negative trend in comparison to other screening 
programs (Figure 1). That is to say, in spite of 
effectiveness increase in these two programs, 
there is a cost decrease showing their cost-
effectiveness. 
A significant point in the cost-effectiveness 
analysis of these programs is the fact that the final 
percent of positive cases was more than two fold 
of the country’s prevalence of opiates 
consumption (i.e. 2.8%) based on United Nations 
Office on Drugs and Crime (UNODC) report.13 It 
is noteworthy to mention that the figure obtained 
by our study (i.e. 5.3%) seems to be less than the 
actual value because of the possibility of false 
negative results due to urine adulteration.10,11 
Some recent studies have found the 
prevalence rate of opiate abuse, in our community 
to be 10% during the last 1.5 days that confirms 
the abovementioned claim.14 
On the other hand, it should be noted that 
even in normal conditions, 23% of opiates 
consumers are missed in urine analysis.15 In spite 
of this, the experiences in developed countries 
have showed that screening of urine samples in 
special groups such as drivers,16 job applicants, 
police officers and laborers6 has caused significant 
decrease of substance abuse in these groups. 
Therefore, considering the cost of substance abuse 
for these groups and the cost resulted from losing 
a job, as well as social costs of addiction, it is wise 
to continue screening programs. According to the 
results of the present study, the screening 
program of referrals of security sections of offices 
needs a thorough revision in regard to the way of 
referring cases.  
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  اي در ﻛﺮﻣﺎن ﻣﻄﺎﻟﻌﻪ: ﺑﺮاي ﺗﺮﻛﻴﺒﺎت ﺷﺒﻪ ﺗﺮﻳﺎك ارزﻳﺎﺑﻲ اﻗﺘﺼﺎدي ﻏﺮﺑﺎﻟﮕﺮي ادرار
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  ﭼﻜﻴﺪه
ﻳﻜﻲ  (ﭘﻴﺎﻣﺪﻫﺎي ﻣﻮرد ﻧﻈﺮ آنﻫﺎي ﺻﺮف ﺷﺪه ﺑﺮاي اﺟﺮاي ﻳﻚ ﺑﺮﻧﺎﻣﻪ ﺑﻪ  ﺑﻪ ﻣﻌﻨﺎي ﻧﺴﺒﺖ ﻫﺰﻳﻨﻪ)ﻫﺰﻳﻨﻪ اﺛﺮﺑﺨﺸﻲ  :ﻣﻘﺪﻣﻪ
ﺗﻌﻴﻴﻦ ﻫﺰﻳﻨﻪ  ،ﻫﺪف از اﻧﺠﺎم اﻳﻦ ﻣﻄﺎﻟﻌﻪ. ﺑﺎﺷﺪ ﻫﺎي ﻏﺮﺑﺎﻟﮕﺮي ﺳﻮء ﻣﺼﺮف ﻣﻮاد اﭘﻴﻮﻳﻴﺪي ﻣﻲ از ﻣﺒﺎﺣﺚ اﺻﻠﻲ در ﺑﺮﻧﺎﻣﻪ
  .اﺛﺮﺑﺨﺸﻲ ﻏﺮﺑﺎﻟﮕﺮي ﻣﻮاد اﭘﻴﻮﻳﻴﺪي از ﻃﺮﻳﻖ آزﻣﺎﻳﺶ ادرار ﺑﻮد
ﻫﺰﻳﻨﻪ اﺛﺮﺑﺨﺸﻲ  .ﺷﺪﻧﺪو دﺳﺘﻪ ﺑﻨﺪي اﻧﺘﺨﺎب ﮔﺮوه ﻣﺠﺰا ﺑﺮ اﺳﺎس دﻟﻴﻞ اﻧﺠﺎم ﻏﺮﺑﺎﻟﮕﺮي  5ﻓﺮد در  89646 اﺑﺘﺪا :ﻫﺎ روش
ﺑﻪ ( ﻫﺎي ﺑﺎﻻﺳﺮي ﺷﺎﻣﻞ ﻫﺰﻳﻨﻪ ﭘﺮﺳﻨﻠﻲ و ﻫﺰﻳﻨﻪ)ﻏﺮﺑﺎﻟﮕﺮي ﺳﻮء ﻣﺼﺮف ﻣﻮاد اﭘﻴﻮﻳﻴﺪي در ﻫﺮ ﮔﺮوه ﺑﺎ ﺗﻘﺴﻴﻢ ﻫﺰﻳﻨﻪ ﻛﻞ 
  .ﮔﺮدﻳﺪﮔﺮوه ﺑﺎ ﻫﻢ ﻣﻘﺎﻳﺴﻪ  5ﺗﻌﺪاد ﻣﻮارد ﻣﺜﺒﺖ ﻛﺸﻒ ﺷﺪه ﻣﺤﺎﺳﺒﻪ ﺷﺪ و ﻧﺘﺎﻳﺞ 
 CLT و (yassa gnineercs dipaR) ASRاﺳﺎس آزﻣﺎﻳﺸﺎت ﺑﺮ ( درﺻﺪ 5/3)ﻓﺮد  0643 ،در ﻣﺠﻤﻮع :ﻫﺎ ﻳﺎﻓﺘﻪ
ﮔﺮوﻫﻲ ﻛﻪ ﺗﻮﺳﻂ ﻧﻴﺮوي اﻧﺘﻈﺎﻣﻲ  ،ﻃﺒﻖ ﺗﺤﻠﻴﻞ ﻫﺰﻳﻨﻪ اﺛﺮﺑﺨﺸﻲ اﻓﺰاﻳﺸﻲ .ﻣﺜﺒﺖ ﺑﻮدﻧﺪ (yhpargotamorhc reyal nihT)
  .(درﺻﺪ 2=  ﻧﻘﻄﻪ ﺳﺮ ﺑﻪ ﺳﺮ)ﺗﺮﻳﻦ ﻏﺮﺑﺎﻟﮕﺮي را داﺷﺘﻨﺪ  دﺳﺘﮕﻴﺮ و ﺟﻬﺖ ﻏﺮﺑﺎﻟﮕﺮي ارﺟﺎع داده ﺷﺪه ﺑﻮدﻧﺪ، ﻣﻘﺮون ﺑﻪ ﺻﺮﻓﻪ
ﻫﺎي ﻏﺮﺑﺎﻟﮕﺮي ﺳﻮء ﻣﺼﺮف ﻣﻮاد اﭘﻴﻮﻳﻴﺪي در ﻛﺸﻮر ﺿﺮوري ﺑﻪ  ﺗﺪاوم ﺑﺮﻧﺎﻣﻪ ،اﺳﺎس ﻧﺘﺎﻳﺞ ﺑﻪ دﺳﺖ آﻣﺪه ﺑﺮ :ﮔﻴﺮي ﻧﺘﻴﺠﻪ
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